The Effectiveness of tDCS And TMS for Treatment of Depression
DOI:
https://doi.org/10.54097/7jm5w890Keywords:
Depression, tDCS, TMS, rTMS.Abstract
Depression is a prevalent mental disorder that can lead to negative emotional states and physical reactions, including pain, insomnia, cognitive disorder and even suicidal tendencies, which largely effect one’s daily life. With the increasing pressures of modern life, the incidence of depression has risen, highlighting the importance of effective treatment. While antidepressants are commonly used, they often come with side effects and may lose effectiveness over time, especially in cases of Treatment-Resistant Depression (TRD) and major depressive disorder (MDD). In order to find a more efficient and safer way to cure depression, neuromodulation techniques has been involved in the treatment. Neuromodulation techniques such as transcranial direct current stimulation (tDCS) and transcranial magnetic stimulation (TMS) have emerged as promising alternatives for depression treatment. These techniques modulate brain activity by applying electric currents or magnetic fields to specific areas of the brain. This study aims to compare tDCS and TMS in the treatment of depression by reviewing their advantages and disadvantages. Results indicate that both tDCS and TMS show promise in treating depression, with tDCS demonstrating moderate effectiveness for acute depression and TMS proving effective, especially for TRD. While both techniques have shown improvements in depressive symptoms, they differ in terms of mechanism, efficacy, safety, and convenience.
Downloads
References
Zhou Q, Li X, Yang D, Xiong C, Xiong Z. A comprehensive review and meta-analysis of neurological side effects related to second-generation antidepressants in individuals with major depressive disorder. Behav Brain Res. 2023; 447:114431.
Padberg, Frank, et al. "Prefrontal transcranial direct current stimulation (tDCS) as treatment for major depression: study design and methodology of a multicenter triple blind randomized placebo controlled trial (DepressionDC)." European archives of psychiatry and clinical neuroscience 2017, 267: 751-766.
Cheng CM, Li CT, Tsai SJ. Current Updates on Newer Forms of Transcranial Magnetic Stimulation in Major Depression. Adv Exp Med Biol. 2021;1305:333-349.
Rezaei M, Shariat Bagheri MM, Khazaei S, Garavand H. tDCS efficacy and utility of anhedonia and rumination as clinical predictors of response to tDCS in major depressive disorder (MDD). J Affect Disord. 2023, 339:756-762.
Koutsomitros T, Evagorou O, Schuhmann T, Zamar A, Sack AT. Advances in transcranial magnetic stimulation (TMS) and its applications in resistant depression. Psychiatriki. 2021, 32:90-98.
Klomjai W, Katz R, Lackmy-Vallée A. Basic principles of transcranial magnetic stimulation (TMS) and repetitive TMS (rTMS). Ann Phys Rehabil Med. 2015;58(4):208-213.
Kito S, Fujita K, Koga Y. Changes in regional cerebral blood flow after repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex in treatment-resistant depression. J Neuropsychiatry Clin Neurosci. 2008, 20(1):74-80.
Zheng A, Yu R, Du W, Liu H, Zhang Z, Xu Z, Xiang Y, Du L. Two-week rTMS-induced neuroimaging changes measured with fMRI in depression. J Affect Disord. 2020, 270:15-21.
Godfrey KEM, Muthukumaraswamy SD, Stinear CM, Hoeh N. Decreased salience network fMRI functional connectivity following a course of rTMS for treatment-resistant depression. J Affect Disord. 2022, 300:235-242.
Cole E J, Stimpson K H, Bentzley B S, et al. Stanford accelerated intelligent neuromodulation therapy for treatment-resistant depression[J]. American Journal of Psychiatry, 2020, 177(8): 716-726.
Jog MA, Anderson C, Kubicki A, Boucher M, Leaver A, Hellemann G, Iacoboni M, Woods R, Narr K. Transcranial direct current stimulation (tDCS) in depression induces structural plasticity. Sci Rep. 2023, 13(1):2841.
D'Urso G, Dell'Osso B, Rossi R, Brunoni AR, Bortolomasi M, Ferrucci R, Priori A, de Bartolomeis A, Altamura AC. Clinical predictors of acute response to transcranial direct current stimulation (tDCS) in major depression. J Affect Disord. 2017, 219:25-30.
Zhang R, Lam CLM, Peng X, Zhang D, Zhang C, Huang R, Lee TMC. Efficacy and acceptability of transcranial direct current stimulation for treating depression: A meta-analysis of randomized controlled trials. Neurosci Biobehav Rev. 2021, 126:481-490.
Nikolin S, Moffa A, Razza L, Martin D, Brunoni A, Palm U, Padberg F, Bennabi D, Haffen E, Blumberger DM, Salehinejad MA, Loo CK. Time-course of the tDCS antidepressant effect: An individual participant data meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2023, 125:110752.
Čukić M. The Reason Why rTMS and tDCS Are Efficient in Treatments of Depression. Front Psychol. 2020; 10:2923.
Rigonatti S P, Boggio P S, Myczkowski M L, et al. Transcranial direct stimulation and fluoxetine for the treatment of depression[J]. European Psychiatry, 2008, 23(1): 74-76.
Perera T, George MS, Grammer G, Janicak PG, Pascual-Leone A, Wirecki TS. The Clinical TMS Society Consensus Review and Treatment Recommendations for TMS Therapy for Major Depressive Disorder. Brain Stimul. 2016; 9(3):336-346.
Voineskos D, Blumberger DM. Transcranial direct current stimulation as a treatment for major depressive disorder. Lancet. 2023;4 02(10401):506-507.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Highlights in Science, Engineering and Technology

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.







